Kurt H. Kruger, Director at Qualigen Therapeutics, Inc. (QLGN), bought 6,000 shares at $3.46 ($21K) on 2020-11-23, disclosed to the SEC on 2020-11-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.55 | 1,400 | $5K | 23.8% |
| 2 | $3.46 | 4,600 | $16K | 76.2% |
| Total | $3.48 avg | 6,000 | $21K | 100% |
| Filing → |